Found: 33
Select item for more details and to access through your institution.
Low‐dose lithium treatment of behavioral complications in Alzheimer's disease: Lit‐AD randomized clinical trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.055194
- By:
- Publication type:
- Article
F4‐02‐03: LITHIUM TREATMENT OF AGITATION IN ALZHEIMER'S DISEASE (LIT‐AD): CLINICAL RATIONALE AND STUDY DESIGN.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1384, doi. 10.1016/j.jalz.2018.06.2870
- By:
- Publication type:
- Article
PLACEBO-CONTROLLED TRIAL OF DONEPEZIL FOLLOWING ANTIDEPRESSANT TREATMENT IN PATIENTS WITH COMORBID DEPRESSION AND COGNITIVE IMPAIRMENT.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2017, v. 13, p. P1571, doi. 10.1016/j.jalz.2017.07.734
- By:
- Publication type:
- Article
A placebo-controlled pilot discontinuation trial following haloperidol treatment of behavioral and psychotic symptoms in Alzheimer's disease
- Published in:
- 2010
- By:
- Publication type:
- Abstract
99mTc HMPAO SPECT prediction of conversion from mild cognitive impairment to Alzheimer's disease
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Comparison of Pittsburgh compound B (11C-PIB) and fluorodeoxyglucose (18F-FDG) PET in patients with Alzheimer's disease, mild cognitive impairment, and healthy controls
- Published in:
- 2009
- By:
- Publication type:
- Abstract
99mTc HMPAO SPECT prediction of conversion from mild cognitive impairment to Alzheimer's disease
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Comparison of Pittsburgh compound B (11C-PIB) and fluorodeoxyglucose (18F-FDG) PET in patients with Alzheimer's disease, Mild Cognitive Impairment and healthy controls
- Published in:
- 2009
- By:
- Publication type:
- Abstract
P2-403: Olfactory performance predicts donepezil response in the high risk to dement elderly with depression and cognitive impairment
- Published in:
- 2008
- By:
- Publication type:
- Abstract
P1-237: PET amyloid imaging with Pittsburgh compound B in Alzheimer's disease, mild cognitive impairment, and healthy controls
- Published in:
- 2008
- By:
- Publication type:
- Abstract
P1-185: The impact of trait anxiety in mild cognitive impairment
- Published in:
- 2008
- By:
- Publication type:
- Abstract
O1-05-07: Predicting conversion from mild cognitive impairment to Alzheimer’s disease
- Published in:
- 2007
- By:
- Publication type:
- Abstract
P-098: Olfactory deficits predict donepezil response in depressed cognitively impaired patients
- Published in:
- 2007
- By:
- Publication type:
- Abstract
P2-112: Correlates of subjective memory complaints in a clinical sample: Relationship to level of impairment
- Published in:
- 2006
- By:
- Publication type:
- Abstract
P2-112: Correlates of subjective memory complaints in a clinical sample: Relationship to level of impairment
- Published in:
- 2006
- By:
- Publication type:
- Abstract
Early markers of Alzheimer’s disease in patients with minimal to mild cognitive impairment
- Published in:
- 2005
- By:
- Publication type:
- Abstract
A Two-Study Comparison of Clinical and MRI Markers of Transition from Mild Cognitive Impairment to Alzheimer's Disease.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
A Two-Study Comparison of Clinical and MRI Markers of Transition from Mild Cognitive Impairment to Alzheimer's Disease.
- Published in:
- International Journal of Alzheimer's Disease, 2012, p. 1, doi. 10.1155/2012/483469
- By:
- Publication type:
- Article
Pittsburgh compound B (11C-PIB) and fluorodeoxyglucose (18 F-FDG) PET in patients with Alzheimer disease, mild cognitive impairment, and healthy controls.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Pittsburgh Compound B (<sup>11</sup>C-PIB) and Fluorodeoxyglucose (<sup>18</sup>F-FDG) PET in Patients With Alzheimer Disease, Mild Cognitive Impairment, and Healthy Controls.
- Published in:
- Journal of Geriatric Psychiatry & Neurology, 2010, v. 23, n. 3, p. 185, doi. 10.1177/0891988710363715
- By:
- Publication type:
- Article
Cerebral Blood Flow and Metabolism in Late-Life Depression and Dementia.
- Published in:
- Journal of Geriatric Psychiatry & Neurology, 1999, v. 12, n. 3, p. 118, doi. 10.1177/089198879901200305
- By:
- Publication type:
- Article
PET Network Abnormalities and Cognitive Decline in Patients with Mild Cognitive Impairment.
- Published in:
- Neuropsychopharmacology, 2006, v. 31, n. 6, p. 1327, doi. 10.1038/sj.npp.1300942
- By:
- Publication type:
- Article
A 10‐item smell identification scale related to risk for Alzheimer's disease.
- Published in:
- Annals of Neurology, 2005, v. 58, n. 1, p. 155
- By:
- Publication type:
- Article
A 10‐item smell identification scale related to risk for Alzheimer's disease.
- Published in:
- Annals of Neurology, 2005, v. 58, n. 1, p. 155
- By:
- Publication type:
- Article
An open treatment trial of duloxetine in elderly patients with dysthymic disorder.
- Published in:
- SAGE Open Medicine, 2014, v. 2, p. 1, doi. 10.1177/2050312114533536
- By:
- Publication type:
- Article
Clinical and radiological characteristics of early versus late mild cognitive impairment in patients with comorbid depressive disorder.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Combined treatment with memantine/es-citalopram for older depressed patients with cognitive impairment: a pilot study.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Vascular depression: overrepresented among African Americans?
- Published in:
- International Journal of Geriatric Psychiatry, 2014, v. 29, n. 5, p. 470, doi. 10.1002/gps.4029
- By:
- Publication type:
- Article
Vascular depression: overrepresented among African Americans?
- Published in:
- International Journal of Geriatric Psychiatry, 2013, v. 28, n. 10, p. 470, doi. 10.1002/gps.4029
- By:
- Publication type:
- Article
A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease.
- Published in:
- International Journal of Geriatric Psychiatry, 2011, v. 26, n. 9, p. 937, doi. 10.1002/gps.2630
- By:
- Publication type:
- Article
The impact of anxiety on conversion from mild cognitive impairment to Alzheimer's disease.
- Published in:
- International Journal of Geriatric Psychiatry, 2009, v. 24, n. 12, p. 1335, doi. 10.1002/gps.2263
- By:
- Publication type:
- Article
Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study.
- Published in:
- International Journal of Geriatric Psychiatry, 2008, v. 23, n. 7, p. 670, doi. 10.1002/gps.1958
- By:
- Publication type:
- Article
Sertraline treatment of elderly patients with depression and cognitive impairment.
- Published in:
- International Journal of Geriatric Psychiatry, 2003, v. 18, n. 2, p. 123, doi. 10.1002/gps.802
- By:
- Publication type:
- Article